Andrew Spiegel (@andrewrspiegel) 's Twitter Profile
Andrew Spiegel

@andrewrspiegel

Patient Advocate, Executive Director Global Colon Cancer Association @GlobalCRC

ID: 59839927

linkhttp://www.globalcca.org calendar_today24-07-2009 17:33:56

1,1K Tweet

1,1K Takipçi

3,3K Takip Edilen

Adam Mossoff (@adammossoff) 's Twitter Profile Photo

WATCH: great 5-minute clip of Andrew Spiegel, Executive Dir. of Colorectal Cancer Alliance, on key function of #patent rights in making possible #innovation in important #cancer cures youtu.be/TY4-NKzy418 IPWatchdog CFIF.org #PatentsMatter #FactsNotRhetoric

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

A six-minute survey can help build educational campaigns and access to #biomarker testing. #ColorectalCancer #ColonCancer #RectalCancer Patients, Survivors, + Caregivers: Share Your Voice! surveymonkey.com/r/JX2BGV6

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

Western #biopharmaceutical companies are fueling the world's recovery from Covid-19 and China is trying to harness that power – and expand its dominance – by supporting a @WTO proposal that would give them access to the companies' revolutionary #protectIP

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

Stephen Harper, former Prime Minister of Canada and International Democracy Union Chairman, hits the nail on the head: China gaining control of Western #biotech IP would squash global competitiveness and fast-track China's economic dominance. #protectIP

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

As the @WTO debates a misguided #IP giveaway, Africa CDC has asked countries to pause #Covid vaccine donations. Director Nkengasong cites logistical challenges + vax hesitancy (not supply) as the barriers to #VaxEquity: politi.co/3w6EVcr United States Trade Representative

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

Via Reuters, Africa's first #Covid vax mfg plant will soon shut down due to lack of demand. So why is Global Trade Watch critiquing WTO rules instead of addressing the lack of demand, vax hesitancy, and logistical challenges impeding vax equity? reut.rs/3904uEc United States Trade Representative

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

Frank Samolis, "Why giving away COVID vaccine patents is a dangerous move," The Detroit News, 5/20/2022 detroitnews.com/story/opinion/… @WTO, USAGov,  #noIPwaiver

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

If Congress is serious about reining in the abusive insurance company and PBM practices, it needs to address the full scope of the problem. Bob Casey, it’s time Washington held middlemen accountable.

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

Colorectal cancer isn’t just a medical term. It’s real life for the millions affected each year. Here is one of those stories. ⁦Baylor University⁩ youtube.com/watch?v=RjjIte…

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

Global collaboration in cancer care and patient advocacy is more critical than ever. Thrilled to be at the Global Cancer Coalitions Network Annual Meeting in Toronto We’re sharing best practices to strengthen cancer patient support and advocacy to improve outcomes for cancer patients worldwide!

safebiologics.org (@safebiologics) 's Twitter Profile Photo

ASBM cofounder Andrew Spiegel of Global Colon Cancer Association and Marcia Horn of ICAN ICAN, International Cancer Advocacy Network discuss how #MFN AKA #MedicinesForNoone Drug Pricing will gut U.S patients' access to new cancer drugs. Importing foreign countries' price controls means importing their reduced access and health

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

Andrew Spiegel , CEO of the Global Colon Cancer Association (GCCA); and Marcia Horn of (ICAN) share the concerns of the cancer patient advocacy community with the recently-announced #MostFavoredNation (MFN) drug pricing policy. youtube.com/watch?v=F2ofBE…

Andrew Spiegel (@andrewrspiegel) 's Twitter Profile Photo

I co-authored a piece in InsideSources highlighting how Donald J. Trump's executive order on drug pricing could cost cancer patients the cures they need. When prices are slashed, innovation suffers, and patients pay the price. dcjournal.com/trumps-drug-pr…